U.S. National Library of MedicineNational Institutes of Health
Skip navigation
MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You MedlinePlus Trusted Health Information for You
  FAQs Site Map About MedelinePlus Contact Us
español
Reuters Health Information Logo

'Good' cholesterol may guard against MS disability

Printer-friendly version E-mail this page to a friend

Reuters Health

Tuesday, April 28, 2009

By Megan Rauscher

NEW YORK (Reuters Health) - High levels of HDL ("good") cholesterol may help protect against disabilities related to multiple sclerosis or MS.

HDL has anti-inflammatory properties and thus it might benefit MS, a disease of chronic inflammation. Preliminary data to support this theory were reported today at the American Academy of Neurology's annual meeting in Seattle.

The findings, study investigator Dr. Bianca Weinstock-Guttman told Reuters Health, suggest that people with MS should have their HDL levels checked. If they're low, "consider dietary and medical interventions, such as statins and fish oil (omega -3) supplements, which are known to increase HDL levels."

Weinstock-Guttman and colleagues from the State University of New York at Buffalo analyzed clinical, demographic and HDL data on 186 MS patients whose average age was 50 years.

At the start of the study, almost 20 percent of the participants had low HDL levels while close to 50 percent had high levels.

Over the next 6 years, an association between the level of HDL cholesterol and the level of disability became apparent. Patients with higher scores on the Expanded Disability Severity Scale (EDSS) initially were significantly less likely to have high levels of HDL at follow-up, the investigators report in printed information made available at the meeting.

"We found that the patients with greater disability, or higher EDSS scores, were almost twice as likely to have low HDL levels compared to patients with less disability, or lower EDSS scores," Weinstock-Guttman added in comments to Reuters Health.

Further studies regarding the relationship between HDL levels and MS disease progression are warranted, the investigators conclude.

"Increase in HDL is an important factor known to prevent cardiovascular events but also appears beneficial in preventing chronic inflammation," Weinstock-Guttman noted, adding that both statins and omega-3s have preliminarily shown "beneficial effects for MS patients."


Reuters Health

© 2009 Thomson Reuters. All rights reserved. Reuters content is the intellectual property of Thomson Reuters or its third party content providers. Any copying, republication or redistribution of Reuters content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. Thomson Reuters shall not be liable for any errors or delays in content, or for any actions taken in reliance thereon. "Reuters" and the Reuters Logo are trademarks of Thomson Reuters and its affiliated companies. For additional information on other Reuters media services please visit http://about.reuters.com/media/.

Related News:
More News on this Date

Related MedlinePlus Pages: